Correlation Between Microsoft and Sensei Biotherapeutics

Can any of the company-specific risk be diversified away by investing in both Microsoft and Sensei Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Microsoft and Sensei Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Microsoft and Sensei Biotherapeutics, you can compare the effects of market volatilities on Microsoft and Sensei Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Microsoft with a short position of Sensei Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Microsoft and Sensei Biotherapeutics.

Diversification Opportunities for Microsoft and Sensei Biotherapeutics

0.65

Correlation Coefficient

Microsoft  Sensei Biotherapeutics

Poor diversification

The 3 months correlation between Microsoft and Sensei is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Microsoft and Sensei Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sensei Biotherapeutics and Microsoft is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Microsoft are associated (or correlated) with Sensei Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sensei Biotherapeutics has no effect on the direction of Microsoft i.e., Microsoft and Sensei Biotherapeutics go up and down completely randomly.

Pair Corralation between Microsoft and Sensei Biotherapeutics

Given the investment horizon of 90 days Microsoft is expected to under-perform the Sensei Biotherapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Microsoft is 2.48 times less risky than Sensei Biotherapeutics. The stock trades about -0.11 of its potential returns per unit of risk. The Sensei Biotherapeutics is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  48.00  in Sensei Biotherapeutics on December 30, 2024 and sell it today you would earn a total of  3.00  from holding Sensei Biotherapeutics or generate 6.25% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Microsoft  vs.  Sensei Biotherapeutics

Microsoft

Risk-Adjusted Performance

Very Weak

Over the last 90 days Microsoft has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's technical and fundamental indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Sensei Biotherapeutics

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Sensei Biotherapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Sensei Biotherapeutics may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with Microsoft and Sensei Biotherapeutics

The main advantage of trading using opposite Microsoft and Sensei Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Microsoft position performs unexpectedly, Sensei Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sensei Biotherapeutics will offset losses from the drop in Sensei Biotherapeutics' long position.

The idea behind Microsoft and Sensei Biotherapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.